Get the Stockscreener App
3.55
0.84%
-0.03
After Hours:
3.55
Briacell Therapeutics Corp stock is traded at $3.55, with a volume of 46,282.
It is down -0.84% in the last 24 hours and up +16.01% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$3.58
Open:
$3.65
24h Volume:
46,282
Relative Volume:
0.23
Market Cap:
$30.88M
Revenue:
-
Net Income/Loss:
$-30.98M
P/E Ratio:
-0.2907
EPS:
-12.2116
Net Cash Flow:
$-31.84M
1W Performance:
-2.61%
1M Performance:
+16.01%
6M Performance:
-27.40%
1Y Performance:
+344.08%
1-Day Range:
$3.46
$3.69
1-Week Range:
$3.46
$3.8499
52-Week Range:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.55 | 31.15M | 0 | -30.98M | -31.84M | -12.21 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Briacell Therapeutics Corp (BCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BriaCell Therapeutics Market Sentiment - Benzinga España
Briacell Therapeutics Corp (BCTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Briacell Therapeutics Corp (BCTX) Income Statement - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.580|Chg%:-0.140 - TradingKey
TradingKey - TradingKey
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXL - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXZ - TradingView
BriaCell Therapeutics Corp Revenue Breakdown – MUN:8BT - TradingView
Briacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Why Briacell Therapeutics Corp stock is sliding today - Wealth Awesome
What's Going On With Briacell Therapeutics Corp Stock Monday? - Wealth Awesome
Is CRA International’s New Bria-IMT Role Quietly Redefining Its Healthcare Moat and Pricing Power (CRAI)? - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site - GuruFocus
What Does BriaCell's Latest Offering Mean for Shareholders - Kavout | AI
Briacell Therapeutics Corp. - Menafn
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Therapeutics Corp. - Baystreet.ca
Why Briacell Therapeutics Corp stock is skyrocketing today - Wealth Awesome
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer - marketscreener.com
Stocks In Play - Baystreet.ca
BriaCell Taps FUJIFILM for Bria-IMT Manufacturing - Contract Pharma
BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufact - GuruFocus
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™ - The Manila Times
What's Going On With Briacell Therapeutics Corp Stock Tuesday? - Wealth Awesome
BriaCell Therapeutics (BCTX) Hovers Near Support After Minor DeclinePairs Trade - dars.gov.et
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT - Investing News Network
BriaCell engages consultants for Bria-IMT commercialization planning - Investing.com
BriaCell engages consultants for Bria-IMT commercialization planning By Investing.com - Investing.com Nigeria
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ - The Manila Times
Why Briacell Therapeutics Corp stock is tanking today - Wealth Awesome
Why Briacell Therapeutics Corp stock is rising today - Wealth Awesome
Why did BCTX stock surge 50% today? - MSN
Number of shareholders of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView
Price to earnings forward of BriaCell Therapeutics Corp – TSX:BCT - TradingView
Price to sales forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView
Price to earnings forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView
Enterprise value to EBIT forward of BriaCell Therapeutics Corp – TSX:BCT - TradingView
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView
Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView
Enterprise value to EBITDA forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView
BriaCell Subsidiary Highlights Interim Results, Ongoing Losses - TipRanks
BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisition - TradingView
BriaCell (NASDAQ: BCTX) unit BriaPro posts loss and acquires sCD80 license - Stock Titan
BriaCell Therapeutics Corp Actuals & Estimates (TSX:BCT) - TradingView
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):